Purchase Order 75N93023P01079
Award Date 8/16/23
Potential Completion Date 8/15/24
Potential Value $23K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sacramento, CA 95826, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $11,820 firm fixed-price purchase order to Novogene Corporation Inc., a Sacramento, California-based minority-owned small business specializing in genomic sequencing and bioinformatics services. Awarded on September 9, 2021, with an ultimate completion date of September 28, 2022, this contract involved no small business set-aside. The award was issued to administratively de-obligate unexpended and expiring fiscal year...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $50,000 purchase order contract to Novogene Corp Inc. to provide next generation sequencing services relating to Ixodes scapularis ticks. The contract has a period of performance from July 7, 2023 through July 6, 2024 and utilizes a firm fixed price contract type. Novogene will perform the sequencing work at its facility located in Sacramento, California to...
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to Novogene Corporation Inc. for $56,640 on August 19, 2021, for premade libraries and lane sequencing for NovaSeq PE 150 sequencing equipment. Novogene is a minority-owned small business based in Sacramento, California. Work is performed in Sacramento, California. The ultimate completion date is September 29, 2022. The solicitation was posted August 4, 2021, with a due date of August 11, 2021, and award date of...
- This federal contract award is for $14,072.00 and was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Novogene Corporation Inc., a minority-owned small business based in Sacramento, California. The contract is for pre-made libraries lane sequencing services, which involves advanced next-generation sequencing technologies including whole genome, transcriptome, metagenomic, and RNA sequencing. This contract has an ultimate completion date of June 30, 2025 and is a...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Novogene Corporation Inc. for $17,010.00 on December 1, 2020, for mRNA sequencing services. Novogene is a minority-owned small business. Work is performed in Sacramento, California. The order is firm fixed price with an ultimate completion date of February 1, 2021.</p>
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Novogene Corp Inc., a minority-owned small business, for RNA sequencing analysis services. The $10,880 contract has a completion date of December 11, 2024 and was not set aside. Novogene is a provider of genomic sequencing and bioinformatics services, supporting various federal agencies' biomedical, agricultural, environmental, and basic research efforts. This award...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $23,084 purchase order to Novogene Corp Inc. to provide whole genome next-generation sequencing services for land sample analysis. The contract has a period of performance of one year from August 2025 through August 2026. The prime contractor Novogene Corp Inc. will perform the sequencing services at its facility located in Sacramento, California. The contract...
- This $20,850 firm fixed-price purchase order was awarded to Novogene Corp Inc., a minority-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 12, 2024. The contract is for RNA sequencing services to support NIAID's biomedical research efforts, with a completion date of September 11, 2025. Novogene is an experienced provider of genomic sequencing and bioinformatics services to various federal agencies, holding multiple prime contracts and...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Novogene Corp Inc., a minority-owned small business, for RNA sequencing analysis services. The $15,900.00 contract will provide plant and animal ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing) services utilizing the Illumina NovaSeq PE150 platform. The work will be performed in Sacramento, California and is expected to be...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for RNA sequencing services. The $13,410.00 contract has a completion date of June 30, 2024. Novogene is a provider of next-generation sequencing technologies and has delivered sequencing and bioinformatics services to support biomedical research across various federal...